Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.
Scope of the Report:
This report focuses on the Argatroban in Global market, especially in North America, Europe and Asia-Pacific, Latin America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Eagle Pharmaceuticals
- Mitsubishi Tanabe Pharma
- Teva Pharmaceutical Industries
Market Segment by Regions, regional analysis covers
- North America (USA, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- Latin America, Middle East and Africa
Market Segment by Type, covers
- Argatroban Powder
- Argatroban Injection
Market Segment by Applications, can be divided into
- Heparin-induced thrombocytopenia (HIT)
- Percutaneous Coronary Intervention
- Cerebral arterial thrombosis
There are 13 Chapters to deeply display the global Argatroban market.
Chapter 1, to describe Argatroban Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Argatroban, with sales, revenue, and price of Argatroban, in 2015 and 2016;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Argatroban, for each region, from 2011 to 2016;
Chapter 5, 6, 7 and 8, to analyze the key regions, with sales, revenue and market share by key countries in these regions;
Chapter 9 and 10, to show the market by type and application, with sales market share and growth rate by type, application, from 2011 to 2016;
Chapter 11, Argatroban market forecast, by regions, type and application, with sales and revenue, from 2016 to 2021;
Chapter 12 and 13, to describe Argatroban sales channel, distributors, traders, dealers, appendix and data source.